The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Production of virus-like particles for vaccines
Open accessAbstract
Highlights • Virus-Like Particles (VLPs) present several advantages over conventional vaccines which make them attractive for vaccination.• Interest in VLP design and production has been increasing in recent years.• Mammalian cell production approach can produce more immunogenic VLPs due to the post-translation modifications accessed.• VLP vaccines against several infectious diseases are already on the market, with others in preclinical and clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., & Charnay, P. (1979) · Nature · doi:10.1038/281646a0 · Cited by 981
The production of recombinant pharmaceutical proteins in plants
Ma, J. K.-C., Drake, P. M. W., & Christou, P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1177 · Cited by 960
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
HIV-1 assembly, budding, and maturation
Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814
Plotkin, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400472111 · Cited by 642
Mammalian cell protein expression for biopharmaceutical production
Zhu, J. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.08.022 · Cited by 491
Recombinant protein therapeutics from CHO cells : 20 years and counting
Jayapal, K. P., Wlaschin, K. F., Hu, W., & Yap, M. G. S. (2007) · Chemical engineering progress · Cited by 473
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
Vaccine manufacturing: challenges and solutions
Ulmer, J. B., Valley, U., & Rappuoli, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1261 · Cited by 376
D’Aoust, M., Couture, M. M. ‐., Charland, N., Trépanier, S., Landry, N., Ors, F., & Vézina, L. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00496.x · Cited by 371
Bioengineering virus‐like particles as vaccines
Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25159 · Cited by 355
Liu, M. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01140.x · Cited by 344
Bright, R. A., Carter, D. M., Daniluk, S., Toapanta, F. R., Ahmad, A., Gavrilov, V., Massare, M., Pushko, P., Mytle, N., Rowe, T., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.106 · Cited by 288
Felberbaum, R. S. (2015) · Biotechnology Journal · doi:10.1002/biot.201400438 · Cited by 264
Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology
Eibl, R., Kaiser, S., Lombriser, R., & Eibl, D. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2422-9 · Cited by 260
Mortola, E., & Roy, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.009 · Cited by 250
Karkey, A., Jombart, T., Walker, A. W., Thompson, C. N., Torres, A., Dongol, S., Tran Vu Thieu, N., Pham Thanh, D., Tran Thi Ngoc, D., Voong Vinh, P., et al. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004346 · Cited by 178
Liu, F., Wu, X., Li, L., Liu, Z., & Wang, Z. (2013) · Protein Expression and Purification · doi:10.1016/j.pep.2013.05.009 · Cited by 163
Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
Metz, S. W., Gardner, J., Geertsema, C., Le, T. T., Goh, L., Vlak, J. M., Suhrbier, A., & Pijlman, G. P. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002124 · Cited by 163
Molecular pharming — VLPs made in plants
Marsian, J., & Lomonossoff, G. P. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.12.007 · Cited by 161
Cervera, L., Gutiérrez-Granados, S., Martínez, M., Blanco, J., Gòdia, F., & Segura, M. M. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.05.001 · Cited by 155
Self-citationBuonaguro, L., Tornesello, M. L., Tagliamonte, M., Gallo, R. C., Wang, L., Kamin‐Lewis, R., Abdelwahab, S. F., Lewis, G. K., & Buonaguro, F. M. (2006) · Journal of Virology · doi:10.1128/jvi.00050-06 · Cited by 137
Hepatitis B vaccines: Protective efficacy and therapeutic potential
Michel, M.-L., & Tiollais, P. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.006 · Cited by 136
The application of virus-like particles as vaccines and biological vehicles
Yan, D., Wei, Y., Guo, H., & Sun, S. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7000-8 · Cited by 130
Assembly of human severe acute respiratory syndrome coronavirus-like particles
Ho, Y.-H., Lin, P.-H., Liu, C. Y. Y., Lee, S.-P., & Chao, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.111 · Cited by 117
Virus-like particles as HIV-1 vaccines
Doan, L. X., Li, M., Chen, C., & Yao, Q. C. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.449 · Cited by 116
Norwalk virus-like particles as vaccines
Herbst‐Kralovetz, M. M., Mason, H. S., & Chen, Q. (2010) · Expert Review of Vaccines · doi:10.1586/erv.09.163 · Cited by 111
Human parvovirus B19: A review
Rogo, L. D., Mokhtari‐Azad, T., Hamid, K. M., & REZAEI, F. (2014) · Acta Virologica · doi:10.4149/av_2014_03_199 · Cited by 108
Vaccines, coming of age after 200 years
Mäkelä, P. H. (2000) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2000.tb00530.x · Cited by 106
Ye, L., Lin, J., Sun, Y., Bennouna, S., Lo, M. K., Wu, Q., Bu, Z., Pulendran, B., Compans, R. W., & Yang, C. (2006) · Virology · doi:10.1016/j.virol.2006.03.021 · Cited by 104
Tan, M., Zhong, W., Song, D., Thornton, S. A., & Jiang, X. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20228 · Cited by 101
Pushko, P., Tumpey, T. M., Hoeven, N. V., Belser, J. A., Robinson, R., Nathan, M., Smith, G., Wright, D. C., & Bright, R. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.059 · Cited by 99
Raising Expectations For Subunit Vaccine
Schiller, J. T., & Lowy, D. R. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu648 · Cited by 94
Luna, J., Plata, M., González, M., Correa, A., Maldonado, I., Nossa, C., Radley, D. R., Vuocolo, S. C., Haupt, R. M., & Saah, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083431 · Cited by 93
Schädlich, L., Senger, T., Kirschning, C. J., Müller, M., & Gissmann, L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.014 · Cited by 76
Thompson, C. M., Petiot, E., Lennaertz, A., Henry, O., & Kamen, A. (2013) · Virology Journal · doi:10.1186/1743-422x-10-141 · Cited by 74
Cervera, L., Gutiérrez-Granados, S., Berrow, N. S., Segura, M. M., & Gòdia, F. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25503 · Cited by 61
Self-citationFontana, D., Kratje, R. B., Etcheverrigaray, M., & Prieto, C. C. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.088 · Cited by 59
Chua, B. Y. L., Johnson, D. F., Tan, A. C. L., Earnest-Silveira, L., Sekiya, T., Chin, R. A. D., Torresi, J., & Jackson, D. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047492 · Cited by 58
Coombs, G. W., Goering, R. V., Chua, K., Monecke, S., Howden, B. P., Stinear, T. P., Ehricht, R., O’Brien, F. G., & Christiansen, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043037 · Cited by 57
Chapter 17: Second generation HPV vaccines to prevent cervical cancer
Schiller, J. T., & Nardelli‐Haefliger, D. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.123 · Cited by 57
Yang, L., Song, Y., Li, X., Huang, X., Liu, J., Ding, H., Zhu, P., & Zhou, P. (2012) · Journal of Virology · doi:10.1128/jvi.07164-11 · Cited by 48
Saldaña, S., Esquivel-Guadarrama, F. R., Olivera-Flores, T. D. J., Arias, N., López, S., Arias, C. F., Ruíz‐Medrano, R., Mason, H. S., Mor, T. S., Richter, L., et al. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.42 · Cited by 46
Virus-free transient protein production in Sf9 cells
Shen, X., Hacker, D. L., Baldi, L., & Wurm, F. M. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.11.018 · Cited by 45
Optimized production of HIV-1 virus-like particles by transient transfection in CAP-T cells
Gutiérrez-Granados, S., Cervera, L., Segura, M. M., Wölfel, J., & Gòdia, F. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7213-x · Cited by 45
Self-citationTaube, S., Kurth, A. A., & Schreier, E. (2005) · Archives of Virology · doi:10.1007/s00705-005-0517-x · Cited by 36
Tagliamonte, M., Visciano, M. L., Tornesello, M. L., Stradis, A. D., Buonaguro, L., & Buonaguro, L. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.004 · Cited by 28
Aucoin, M. G., Jacob, D., Chahal, P. S., Meghrous, J., Bernier, A., & Kamen, A. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-457-5_14 · Cited by 26
Cited by
Nooraei, S., Bahrulolum, H., Hoseini, Z. S., Katalani, C., Hajizade, A., Easton, A. J., & Ahmadian, G. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00806-7 · Cited by 869
A systematic review of SARS-CoV-2 vaccine candidates
Dong, Y., Dai, T., Wei, Y., Zhang, L., Zheng, M., & Zhou, F. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00352-y · Cited by 545
Gee, P., Lung, M. S. Y., Okuzaki, Y., Sasakawa, N., Iguchi, T., Makita, Y., Hozumi, H., Miura, Y., Yang, L. F., Iwasaki, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14957-y · Cited by 362
Efficacy and safety of COVID-19 vaccines
Graña, C., Ghosn, L., Evrenoglou, T., Jarde, A., Minozzi, S., Bergman, H., Buckley, B. S., Probyn, K., Villanueva, G., Henschke, N., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015477 · Cited by 310
Recent Advances in CRISPR/Cas9 Delivery Strategies
Yip, B. (2020) · Biomolecules · doi:10.3390/biom10060839 · Cited by 292
Metadata
- Authors
- Fuenmayor, J., Gòdia, F., & Cervera, L.
- Venue
- New Biotechnology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 39
- Issue
- Pt B
- Pages
- 174-180
- ISSN
- 1871-6784 (ISSN-L)
- OpenAlex
- W2741681003
- Cited by
- 318
- References
- 52
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.